We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIC icon
1951
Nicolet Bankshares
NIC
$3.62B
$28K ﹤0.01%
+452
New +$27.3K
OFS icon
1952
OFS Capital
OFS
$51.9M
$28K ﹤0.01%
2,277
+2,211
+3,350% +$27.2K
POR icon
1953
Portland General Electric
POR
$5.77B
$28K ﹤0.01%
511
-840
-62% -$44.5K
STRT icon
1954
STRATTEC Security
STRT
$361M
$28K ﹤0.01%
1,160
+861
+288% +$23.5K
SYNA icon
1955
Synaptics
SYNA
$4.15B
$28K ﹤0.01%
933
-828
-47% -$27K
TPVG icon
1956
TriplePoint Venture Growth BDC
TPVG
$211M
$28K ﹤0.01%
1,937
-3,109
-62% -$43.6K
TRIP icon
1957
TripAdvisor
TRIP
$1.26B
$28K ﹤0.01%
612
-3,582
-85% -$175K
TTE icon
1958
TotalEnergies
TTE
$190B
$28K ﹤0.01%
+500
New +$27.3K
URBN icon
1959
Urban Outfitters
URBN
$6.59B
$28K ﹤0.01%
1,217
-2,964
-71% -$80.3K
PVLA
1960
Palvella Therapeutics
PVLA
$2.27B
$28K ﹤0.01%
73
+67
+1,117% +$20K
VRS
1961
DELISTED
Verso Corporation
VRS
$28K ﹤0.01%
+1,473
New +$29.8K
ANSS
1962
DELISTED
Ansys
ANSS
$27K ﹤0.01%
130
-1,583
-92% -$302K
AXDX
1963
DELISTED
Accelerate Diagnostics
AXDX
$27K ﹤0.01%
+120
New +$23.5K
EMN icon
1964
Eastman Chemical
EMN
$8.42B
$27K ﹤0.01%
340
-7,924
-96% -$602K
EVRI
1965
DELISTED
Everi Holdings
EVRI
$27K ﹤0.01%
2,297
+1,339
+140% +$14.5K
FPI
1966
Farmland Partners
FPI
$432M
$27K ﹤0.01%
3,840
-5,040
-57% -$32.6K
HCSG icon
1967
Healthcare Services Group
HCSG
$1.53B
$27K ﹤0.01%
882
-1,177
-57% -$38.9K
HWBK icon
1968
Hawthorn Bancshares
HWBK
$278M
$27K ﹤0.01%
1,204
+503
+72% +$10.6K
INSG icon
1969
Inseego
INSG
$90.5M
$27K ﹤0.01%
555
-1,896
-77% -$89.2K
OKE icon
1970
Oneok
OKE
$54.5B
$27K ﹤0.01%
396
-9,102
-96% -$613K
PGRE
1971
DELISTED
Paramount Group
PGRE
$27K ﹤0.01%
1,904
-8,581
-82% -$124K
PLOW icon
1972
Douglas Dynamics
PLOW
$1.02B
$27K ﹤0.01%
672
-2,393
-78% -$91.1K
QCOM icon
1973
Qualcomm
QCOM
$176B
$27K ﹤0.01%
359
-22,147
-98% -$1.62M
QUAL icon
1974
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
$27K ﹤0.01%
300
-34,269
-99% -$3.08M
SKT icon
1975
Tanger
SKT
$4.52B
$27K ﹤0.01%
1,657
-3,999
-71% -$72.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.